Patents by Inventor Jorg Senn-Bilfinger

Jorg Senn-Bilfinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220370425
    Abstract: A method is described in which treatment is carried out with compounds of tetrahydropyridoethers that are administered in form of a medication to treat AMD and to remove lipofuscin from a patient's eye.
    Type: Application
    Filed: July 14, 2022
    Publication date: November 24, 2022
    Applicants: Katairo GmbH, Takeda GmbH
    Inventors: Ulrich Schraermeyer, Jörg Senn-Bilfinger, Ernst Sturm
  • Patent number: 10495630
    Abstract: A method for selecting a compound or a composition suitable for treating lipofuscin associated diseases in a patient, the method including the steps of determining a reactivity factor, determining a targeting factor that allows an uptake into a cell and a provides a targeting of lipofuscin, and selecting a compound or a composition or combining compounds to obtain a compound or composition that comprises a reactivity factor and an targeting factor.
    Type: Grant
    Filed: February 13, 2015
    Date of Patent: December 3, 2019
    Assignees: KATAIRO GMBH, TAKEDA GMBH
    Inventors: Ulrich Schraermeyer, Michael Burnet, Jörg Senn-Bilfinger, Ernst Sturm, Guido Hanauer
  • Publication number: 20090093473
    Abstract: The invention provides compounds of the formula (I) In which the substituents and symbols are as defined in the description. The compounds inhibit the secretion of gastric acid.
    Type: Application
    Filed: June 13, 2006
    Publication date: April 9, 2009
    Inventors: Peter Jan Zimmermann, Jorg Senn-Bilfinger, Christof Brehm, Wilm Buhr, Maria Vittoria Chiesa, Andreas Palmer, Wolfgang-Alexander Simon, Stefan Postius, Wolfgang Kromer
  • Patent number: 7393860
    Abstract: The compound (7R,8R,9R)-2,3-Dimethyl-8-hydroxy-7-(2-methoxyethoxy)-9-phenyl-7,8,9,10-tetrahydro-imidazo-[1,2-h] [1,7] naphthyridine inhibits the secretion of gastric acid.
    Type: Grant
    Filed: July 27, 2006
    Date of Patent: July 1, 2008
    Assignee: Altana Pharma AG
    Inventor: Jörg Senn-Bilfinger
  • Patent number: 7326718
    Abstract: The present invention relates to 8-substituted imidazopyridines of a certain formula (1) in which the substitutents and symbols have the meanings indicated in the description. The compounds have gastric secretion inhibiting and excellent gastric and intestinal protective action properties.
    Type: Grant
    Filed: November 15, 2003
    Date of Patent: February 5, 2008
    Assignee: Altana Pharma AG
    Inventors: Wilm Buhr, Jörg Senn-Bilfinger, Peter Jan Zimmermann
  • Patent number: 7314935
    Abstract: The invention relates to compounds of the formula (1) where the substituents and symbols are as defined in the description. The compounds are valuable intermediates for preparing active pharmaceutical ingredients.
    Type: Grant
    Filed: February 12, 2003
    Date of Patent: January 1, 2008
    Assignee: Altana Pharma AG
    Inventors: Wilm Buhr, Jörg Senn-Bilfinger, Peter Jan Zimmerman, Peter Zimmerman
  • Patent number: 7223771
    Abstract: The invention provides compounds of the formula (I), in which the substituents and symbols are as defined in the description. The compounds inhibit the secretion of gastric acid.
    Type: Grant
    Filed: July 31, 2002
    Date of Patent: May 29, 2007
    Assignee: Altana Pharma AG
    Inventors: Wilm Buhr, Jörg Senn-Bilfinger
  • Patent number: 7189736
    Abstract: Compounds of formula 1, in which the substituents have the meanings mentioned in the description are suitable for the prevention and treatment of gastrointestinal diseases.
    Type: Grant
    Filed: April 19, 2004
    Date of Patent: March 13, 2007
    Assignee: Altana Pharma AG
    Inventors: Jörg Senn-Bilfinger, Wilm Buhr
  • Patent number: 7141567
    Abstract: The invention relates to imidazopyridines of a certain formula 1, in which the substituents and symbols have the meanings indicated in the description. The compounds have gastric secretion-inhibiting properties.
    Type: Grant
    Filed: May 24, 2004
    Date of Patent: November 28, 2006
    Assignee: Altana Pharma AG
    Inventors: Jörg Senn-Bilfinger, Wilm Buhr, Peter Zimmermann, Bernhard Kohl
  • Patent number: 7105676
    Abstract: Compounds of formula (1) in which the substituents have the meanings mentioned in the description, are suitable for the prevention and treatment of gastrointestinal diseases.
    Type: Grant
    Filed: February 23, 2004
    Date of Patent: September 12, 2006
    Assignee: Altana Pharma AG
    Inventor: Jörg Senn-Bilfinger
  • Publication number: 20060100234
    Abstract: The present invention relates to 8-substituted imidazopyridines of a certain formula (1) in which the substitutents and symbols have the meanings indicated in the description. The compounds have gastric secretion inhibiting and excellent gastric and intestinal protective action properties.
    Type: Application
    Filed: November 15, 2003
    Publication date: May 11, 2006
    Applicant: Altana Pharma AG
    Inventors: Wilm Buhr, Jorg Senn-Bilfinger, Peter Zimmermann, Wilm Buhr, Jorg Senn-Bilfinger, Wolfgang-Alexander Simon, Stefan Postius, Wolfgang Kromer
  • Patent number: 7034178
    Abstract: This invention is drawn to a process for the production of (R,R)-phenylisoserine or a 1–4C-alkyl ester thereof.
    Type: Grant
    Filed: June 27, 2002
    Date of Patent: April 25, 2006
    Assignee: Altana Pharma AG
    Inventors: Wijnand Faber, Jan Koek, Jörg Senn-Bilfinger, Ton Vries
  • Publication number: 20060041163
    Abstract: The invention relates to a process for preparation of (R, R)-3-phenylisoserine and its derivates.
    Type: Application
    Filed: October 14, 2005
    Publication date: February 23, 2006
    Inventors: Wijnand Faber, Jan Koek, Jorg Senn-Bilfinger, Ton Vries
  • Publication number: 20060041134
    Abstract: Compounds of the formula 1, in which the substituents have the meanings mentioned in the description are valuable intermediates for preparing active compounds for the prevention and treatment of gastro-intestinal diseases.
    Type: Application
    Filed: December 18, 2003
    Publication date: February 23, 2006
    Applicant: Altana Pharma AG
    Inventors: Jan Koek, Bernhard Kohl, Jorg Senn-Bilfinger, Ton Vries
  • Publication number: 20060035892
    Abstract: The invention relates to nitrosated imidazopyridines of a certain formula (I), in which the substituents and symbols have the meanings indicated in the description. The compounds have gastric secretion-inhibiting, anti-inflammatory and antibacterial properties.
    Type: Application
    Filed: April 22, 2003
    Publication date: February 16, 2006
    Applicant: Atlanta Pharma AG
    Inventors: Wilm Buhr, Jorg Senn-Bilfinger, Peter Zimmermann
  • Patent number: 6936623
    Abstract: Compounds of the formula (I), in which the substituents have the meanings mentioned in the description, are suitable for the prevention and treatment of gastrointestinal diseases.
    Type: Grant
    Filed: April 1, 2004
    Date of Patent: August 30, 2005
    Assignee: Altana Pharma AG
    Inventors: Jörg Senn-Bilfinger, Wilm Buhr
  • Patent number: 6927292
    Abstract: The invention relates to compounds of Formula (1), in which the substituents and symbols have the meanings indicated in the description. The compounds are valuable intermediates for the preparation of pharmaceutical active compounds.
    Type: Grant
    Filed: July 31, 2002
    Date of Patent: August 9, 2005
    Assignee: Altana Pharma AG
    Inventors: Jörg Senn-Bilfinger, Peter Jan Zimmermann
  • Patent number: 6916825
    Abstract: Compounds of the formula 1 in which the substituents have the meanings mentioned in the description are suitable for the prevention and treatment of gastrointestinal diseases.
    Type: Grant
    Filed: March 28, 2001
    Date of Patent: July 12, 2005
    Assignee: Altana Pharma AG
    Inventors: Jörg Senn-Bilfinger, Wilm Buhr
  • Publication number: 20050148618
    Abstract: The invention relates to compounds of the formula (1) where the substituents and symbols are as defined in the description. The compounds are valuable intermediates for preparing active pharmaceutical ingredients.
    Type: Application
    Filed: February 12, 2003
    Publication date: July 7, 2005
    Inventors: Wilm Buhr, Jorg Senn-Bilfinger, Peter Zimmermann, Peter Zimmermann
  • Patent number: 6869949
    Abstract: The invention relates to imidazopyridines of a certain formula 1, in which the substituents and symbols have the meanings indicated in the description. The compounds have gastric secretion-inhibiting properties.
    Type: Grant
    Filed: October 23, 2001
    Date of Patent: March 22, 2005
    Assignee: Altana Pharma AG
    Inventors: Jörg Senn-Bilfinger, Wilm Buhr, Peter Zimmermann, Bernhard Kohl